µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º E )2/Vn2
<N3~X,ch
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ ;ULw-&]P
Nz%pl!
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) @X=sfygk
ch0cFF^]
1. ICAM-1 3K/]{ dkD
fG{3S:TQq
2. interleukin 12(IL-12) "#iO{uMWb
h]IoH0/
3. tumor infiltrating lymphocyte }r"E\~E
yA7O<p+
4. TCR/CD3 complex
Y^|15ek
V9%9nR!'
5. hematopoietin receptor family SCfk!GBVD
=PnNett}a
6. individual idiotype(IdI)
0BAZWm
IWwOP{ <ZQ
7. integrin f/Z-dM\e
ZvK
3Su)f1
8. colony-stimulatory factor (CSF) A.YK=_J
{3!A\OR
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© h645;sb0
0t*PQ%
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? x/0x&la
OSom-?|w
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ =YtK@+| i
:73T9/
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷ÓᣠEh"Y<]$
"#{b)!EH
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ t=[/
L]!
1o)<23q`)
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) JBISA _Y
Z(J
1A x
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ 4dh>B>Q
jank<Q&w
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) ubsx NCqD
TdoH((nY
3. immunoglobulin superfamily (IgSF) bnE&-N*
QKoJxjR=^
4. selectin rPHM_fW(O@
[c99m:*+
5. anti-idiotypic antibody (¦ÁId) V{rQ@7SE
yT(86#st
6. major histocompatibility complex(MHC) HaOSFltf#
ork{a.1-_w
7. immunotolerance **ls 4CE<
I*(7(>zgyv
8. biological reponse modifier(BRM) nYK!'x$
i2\CDYP
9. immune reponse gene (Ir gene) g#5t8w
R
LDu5
10. reshaped antibody (or reconstituted antibody) _cbXzSYq&
AgdU@&^
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© 0LP>3"Sm
1mx;b)4t
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ JOki4N
*(VwD)*
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? xf{=~j/L
a#3,qp!
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£
VO*fC
A
E%zqvp>
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? ~hU^5R-%
}i\_`~
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ QFEc?sEe
By0Zz
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? cLMFC1=b
"o<&3c4
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ e73zpF
"3NE%1T
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ x4@IK|CE
5%R$7>`Z
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? x]:B3_qR
!p4FK]B/u
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ q.p.y0
W;
?'
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: /909ED+)>9
TfFH!1^+
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: lQer|?#
>2<
Jb!f&
̉񧄤 Iy{&T#e"
B,ZLX/c9
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© I~7eu&QZ
}m-+EUEo9
1. CD8 d##'0yg
[Ma
d~;
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) ZCCwx71j
KEvT."t
3. immunoglobulin fold(Ig fold) {@`Z`h"N
z
T#j.v
4. cadherin (Ca-dependent cell adhesion moleculers) ,W~a%8*
RU
GhhK
5. idiotype-anti-idiotypic antibody immune network theory h8tKYm
0%<x>O
6. HLA class II antigen <YBA
7i
-!z,t7!
7. complementarity-determining region (CDR) ^H
UNq[sQ
gdyP,zMD7
8. perforin(or pore-forming protein ,PFP) 'Ijjk`d&c
Z'L}x6
9. high affinity IL-2 receptor _,;|,
^8r4tX
10. artificial active immunization 7ehs+GI
VXtW{*{"
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© 4RV5:&ALLS
DU/WB
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠ@ \(*pa
vo_m$ /O
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 O0i[GCtP5
{ f
@k2^
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ H%:~&_D
1
]uHaI(
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ =c, m)\u/8
"`AIU}[_I
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ cR+9^DzA
;nbUbRb
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? _ ecKX</Q
cDS6RO?
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ]#N~r&hmQ
9_mys}+
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ PKhH0O\_U
'K=n}}&
:
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ 0b0.xz\~U
csV.AN'obq
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ ]$'w8<D>t,
Vb
`m3
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© R&BbXSIDX
R30{/KK
1. immunoglobulin gene rearrangement _[8BAm
!'()QtvC<
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) q1Vh]d
YH(
54R
3. flow cytometry(FCM) :66xrw
t
c%?{W\
4. carrier effect %.kJ@@_e
QQ4
&,d
5. positive selection of T lymphocytes in thymus :bxq%D%|o
`gIlS^Q
6. mouse TH1(Th1) and TH2(Th2) subsets /h=:heS4$
\lVxlc0{?
7. perforin (pore-forming protein ,PFP) UC)-Fd
7tgn"wK
8. ADCC(antibody-dependent cell-mediated cytotoxicity) }5Yd:%u5
n22k<@y
9. SH-2(src-homology region 2) -,NiSh}A
sM)n-Yy#9
10. Ab2¦Â (internal image) m&xyw9a
@G0k+
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© qkpnXQ
gbOd(ugH
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? RkVU^N"
,/n<Qg"`
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? L4I1n l
KlbL<9P>
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦ÓᣠiGmBG1a\
*k:Sg*neVq
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£
Xk[;MZ[
3-4' x2
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦Óᣠsr!m
` z<k7ig
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) {7!WtH;-
,"!t[4p=f
ÃâÒßѧרҵ£º FBpf_=(_1
6]#pPk8[Z
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ d4h1#MK
`~'yy q
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? {S4^;Va1
3*9<JHu
´«È¾²¡Ñ§×¨Òµ£º %;+Q0
e9
U5
~L^
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ }r:H7&|&
c`
^I% i
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ )N!-g47o%#
?k)(~Y&@p
Ïû»¯×¨Òµ£º dx{ZG'@aH
-}nTwx:|5u
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ FV|/o%XqK
bgs2~50
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? KF&1Y>t=
HhkubG)\
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ |U}al[
__jFSa`at
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© l!z0lh-J
sr(f9Vl
1. Fas(CD95)/FasL ,<]X0;~oB
N-
E)b
2. common chain of cytokine receptor |`d5Y#26
B 14Ziopww
3 . TCR/CD3 complex \yeo-uN8
/lBx}o'
4. negaive selection of thymocytes L$*sv
.
Qx,jUL#2
5. artificial active immune G5~ Jp#uA
r
|[uR$|Y
6. anti-idiotypic '{9
nQDgT
Y{~[N y E
7. IgSF Ys |n9pW
(h;4irfX
8. Integrin 'Q\I@s }
k`H#u, &